Maison Solutions Inc. Class A Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSS research report →
Price Chart
About the company
Maison Solutions Inc. , along with its affiliated entities, functions as a niche grocery retailer across California. The company offers a wide array of products, including fresh perishables like meats, seafood, fruits, and vegetables.
- CEO
- Jun Xu
- IPO
- 2023
- Employees
- 329
- HQ
- Monterey Park, CA, US
Get TickerSpark's AI analysis on MSS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.30M
- P/E
- -0.06
- Fwd P/E
- 1.18
- PEG
- 0.00
- P/S
- 0.01
- P/B
- 0.11
- EV/EBITDA
- -4.35
- Div Yield
- 0.00%
- Gross Margin
- 20.17%
- Op Margin
- -7.63%
- Net Margin
- -10.56%
- ROE
- -116.86%
- ROIC
- -13.67%
Latest fiscal year · YoY change
- Revenue
- $124.22M+114.0%
- Gross Profit
- $26.34M+126.7%
- Op Income
- $-1,265,006
- Net Income
- $1.17M+135.0%
- EPS
- $3.35+135.3%
- OCF Growth
- +235.8%
- FCF Growth
- +167.0%
- 52W High
- $44.35
- 52W Low
- $1.24
- 50D MA
- $1.56
- 200D MA
- $6.85
- Beta
- 4.03
- RSI (14)
- 48
- Avg Volume
- 4.14M
No earnings-call transcripts are available for MSS yet.
- Free Float
- 64.7%
- Shares Outstanding
- 810.54K
- Float Shares
- 524.11K
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 5 ETFs
Biggest fund positions in MSS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 3, 26 | Cao Xi | other | 1,500 |
| Sep 3, 26 | Lopez Alexandria M. | other | 25,000 |
| Aug 18, 26 | HRT FINANCIAL LP | sell | 32,556 |
| Aug 14, 26 | HRT FINANCIAL LP | sell | 134,000 |
| Aug 17, 26 | HRT FINANCIAL LP | sell | 20,394 |
| Aug 13, 26 | HRT FINANCIAL LP | buy | 7,553 |
| Aug 12, 26 | HRT FINANCIAL LP | buy | 22,559 |
| Aug 10, 26 | HRT FINANCIAL LP | buy | 4,616 |
| Aug 11, 26 | HRT FINANCIAL LP | sell | 4,329 |
| Aug 7, 26 | HRT FINANCIAL LP | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MSS coverage
Recent articles, reports, and earnings notes.
No research on MSS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MSS report →Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
gurufocus.com · Oct 2
Maison Solutions Inc. Receives Additional Nasdaq Notification Regarding Delayed Filing of Quarterly Report on Form 10-Q
accessnewswire.com · Sep 29
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
globenewswire.com · Sep 28
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
prnewswire.com · Sep 1
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
gurufocus.com · Aug 28
Maison Solutions Eliminates All Outstanding Convertible Notes, Removing Legacy Financing Overhang
accessnewswire.com · Aug 26
Maison Solutions Inc. Receives Nasdaq Notification Regarding Delayed Filing of Annual Report on Form 10-K
accessnewswire.com · Aug 25
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
gurufocus.com · Aug 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.